Update shared on 27 Nov 2025
Fair value Decreased 0.053%Heineken's analyst price target has been modestly reduced, with updated estimates reflecting a decrease of approximately EUR 0.05. Analysts cite factors such as a slightly higher discount rate and revised expectations for revenue growth and margins.
Analyst Commentary
Analyst sentiment toward Heineken remains mixed, with recent price target adjustments and ratings reflecting both confidence and caution in the company’s outlook. The analysis focuses on valuation changes, execution risks, and projections for future growth.
Bullish Takeaways- Bullish analysts have raised their price targets, pointing to improved confidence in Heineken’s long-term valuation and upside potential.
- Positive rating actions are linked to expectations for ongoing revenue growth and margin expansion over the forecast period.
- Increased targets reflect optimism around Heineken’s ability to manage operational costs and navigate challenging macroeconomic conditions.
- Analysts adopting a 'Buy' stance cite effective execution and a solid brand portfolio as catalysts for continued performance.
- Bearish analysts have lowered price targets in response to anticipated declines in quarterly volume growth, particularly in specific geographic segments.
- There is caution around short-term headwinds, including market volatility and pressures on consumer demand that could impact revenue and profit margins.
- The maintenance of Hold ratings signals a preference for a wait-and-see approach amid mixed signals about immediate earnings trajectory.
- Some expect margin and revenue growth to moderate, citing recent performance trends and competitive factors within the sector.
What's in the News
- Heineken outlined its new EverGreen 2030 strategy, which targets mid-single-digit organic net revenue growth, organic operating profit growth ahead of revenue, and maintains over 90% cash conversion through productivity initiatives and an expanded focus on sustainability. (Key Developments)
- The company provided earnings guidance for the full year 2025, anticipating organic operating profit growth toward the lower end of its 4% to 8% range. (Key Developments)
- Heineken celebrated the installation of its 10,000th Heineken 0.0 draught outlet in Europe, reinforcing its leadership in the alcohol-free beer category and highlighting the growing demand for non-alcoholic options across key markets. (Key Developments)
Valuation Changes
- Fair Value: The consensus fair value estimate for Heineken has edged down slightly from €86.28 to €86.23.
- Discount Rate: The applied discount rate has risen moderately, moving from 4.99% to 5.17%.
- Revenue Growth: Projected annual revenue growth has increased modestly to 3.68% compared to the prior estimate of 3.63%.
- Net Profit Margin: Expected net profit margin has improved, rising from 8.58% to 9.07%.
- Future P/E: The forecast future price-to-earnings ratio has declined to 18.92x from the previous 19.93x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.